Skip to content
Top Globe News – Lifestyle
Author:
Ansun Biopharma, Inc.
Ansun Biopharma Announces Independent Data Monitoring Committee Recommendation Supporting Continued Phase 3 Development of DAS181 in Immunocompromised Patients with Parainfluenza Infection
June 1, 2026